Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients

Galatea Kallergi(University of Crete), Sofia Agelaki(University of Crete)

Breast Cancer Research

June 1, 2011

10.1186/bcr2896

Cited by 373

Related Papers

Clinical Relevance of Immune Checkpoints on Circulating Tumor Cells in Breast Cancer

|Cancers|2020|88

Efficacy of Lapatinib in Therapy-Resistant HER2-Positive Circulating Tumor Cells in Metastatic Breast Cancer

|PLoS ONE|2015|58

Expression of insulin‐like growth factor‐1 receptor in circulating tumor cells of patients with breast cancer is associated with patient outcomes

|Molecular Oncology|2017|17

PD-L1/pS6 in Circulating Tumor Cells (CTCs) during Osimertinib Treatment in Patients with Non-Small Cell Lung Cancer (NSCLC)

|Biomedicines|2022|11